Cell Medx Corp Stock Net Income
| CMXCDelisted Stock | USD 0.48 0.16 50.00% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Cell MedX's long-term financial health and intrinsic value.
Cell |
Cell MedX Corp OTC Stock Net Income Analysis
Cell MedX's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Cell MedX Net Income | (910.84 K) |
Most of Cell MedX's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cell MedX Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Cell MedX Corp reported net income of (910,836). This is 100.27% lower than that of the Health Care Equipment & Supplies sector and 100.38% lower than that of the Health Care industry. The net income for all United States stocks is 100.16% higher than that of the company.
Cell Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cell MedX's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Cell MedX could also be used in its relative valuation, which is a method of valuing Cell MedX by comparing valuation metrics of similar companies.Cell MedX is currently under evaluation in net income category among its peers.
Cell Fundamentals
| Return On Asset | -5.62 | |||
| Operating Margin | (297.67) % | |||
| Current Valuation | 1.91 M | |||
| Shares Outstanding | 62.92 M | |||
| Shares Owned By Insiders | 50.37 % | |||
| Price To Earning | (5.25) X | |||
| Price To Sales | 591.58 X | |||
| Revenue | 6.76 K | |||
| Gross Profit | (39.05 K) | |||
| EBITDA | (680.15 K) | |||
| Net Income | (910.84 K) | |||
| Cash And Equivalents | 30.74 K | |||
| Total Debt | 343.67 K | |||
| Debt To Equity | (1.19) % | |||
| Current Ratio | 0.03 X | |||
| Book Value Per Share | (0.03) X | |||
| Cash Flow From Operations | (560.43 K) | |||
| Earnings Per Share | (0.01) X | |||
| Number Of Employees | 11 | |||
| Beta | 0.61 | |||
| Market Capitalization | 1.82 M | |||
| Total Asset | 52.24 K | |||
| Retained Earnings | (6.43 M) | |||
| Working Capital | 40.25 K | |||
| Current Asset | 61.84 K | |||
| Current Liabilities | 21.6 K | |||
| Net Asset | 52.24 K |
About Cell MedX Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cell MedX Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cell MedX using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cell MedX Corp based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in median. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in Cell OTC Stock
If you are still planning to invest in Cell MedX Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cell MedX's history and understand the potential risks before investing.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |